News

Articles

This self-emulsifying system improves the miscibility and dispersibility of formulations in aqueous environments and may improve API solubility.

SuspendIt Anhydrous Introduced as New Compounding Base

The definitive agreement will give AstraZeneca global rights to CinCor’s portfolio of cardiorenal disease treatments.

AstraZeneca Inks $1.8 Billion Acquisition for CinCor Pharma

Ipsen’s $952 million acquisition of Albireo is designed to bolster the company's rare disease portfolio.

Ipsen to Bolster Liver Disease Portfolio with Albireo Acquisition

Sartorius and RoosterBio will work together to address purification challenges and establish scalable downstream manufacturing processes for exosome-based therapies.

Sartorius and RoosterBio Strike Downstream Collaboration Deal

Eisai’s Alzheimer’s treatment, Leqembi (lecanemab-irmb), received approval from FDA via the Accelerated Approval pathway.

FDA Grants Accelerated Approval for Eisai Alzheimer’s Disease Treatment

Astrea Bioseparations has acquired Delta Precision, a manufacturer of chromatography columns for biomanufacturing.

Astrea Bioseparations Acquires Delta Precision

Agilent’s acquisition of Avida grants them access to high-performance enrichment workflows that enable NGS approaches for studying cancer.

Agilent Acquires Life Sciences Company Avida Biomed

Merck, known as MSD outside of the United States and Canada, will pay Kelun-Biotech up to $9l3 billion for seven early-stage oncology treatments.

Merck Licenses Kelun-Biotech ADC’s in Deal Worth $9.3 Billion

FDA has announced that bebtelovimab is not currently authorized for emergency use in any region of the US. 

FDA Announces Bebtelovimab is Not Currently Authorized in Any US Region

Sosei Heptares and Eli Lilly have entered a multi-target collaboration and license agreement in diabetes and metabolic diseases. 

Biopharma News